Role of substance P and bradykinin in acute pancreatitis induced by secretory phospholipase A2

Pancreas

Volumn 37, Issue 1, 2008, Pages 50-55

  Camargo, Enilton A ^a   Ferreira, Tatiane ^a   Ribela, Maria Teresa C P ^b   De Nucci, Gilberto ^a   Landucci, Elen C T ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute pancreatitis; Bradykinin 2 receptor; Neurokinin 1 receptor; Phospholipases A2

Indexed keywords

AMYLASE; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; ICATIBANT; LUNG ENZYME; MYELOPEROXIDASE; NEUROKININ 1 RECEPTOR; NOLPITANTIUM; PANCREAS ENZYME; SECRETORY PHOSPHOLIPASE A2; SNAKE VENOM; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; BRADYKININ B2 RECEPTOR; DRUG DERIVATIVE; PEROXIDASE; PIPERIDINE DERIVATIVE; QUINUCLIDINE DERIVATIVE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMMON BILE DUCT; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; EVALUATION; EXTRAVASATION; INFLAMMATION; LUNG; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; ACUTE DISEASE; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PANCREATITIS; PNEUMONIA; WISTAR RAT;

ACUTE DISEASE; AMYLASES; ANIMALS; BRADYKININ; DISEASE MODELS, ANIMAL; LUNG; MALE; PANCREAS; PANCREATITIS; PEROXIDASE; PHOSPHOLIPASES A2, SECRETORY; PIPERIDINES; PNEUMONIA; QUINUCLIDINES; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, NEUROKININ-1; SUBSTANCE P; TUMOR NECROSIS FACTOR-ALPHA;

EID: 46349089907     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3185d9b9b     Document Type: Article

References (51)

1. Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy. 2002;1:343-351.
2. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of the acute pancreatitis: a systematic review. Pancreas. 2006;33:323-330.
3. Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol. 2000;190,117-125.
4. Liddle RA, Nathan JD. Neurogenic inflammation and pancreatitis. Pancreatology. 2004;4:551-559.
5. 2 enzymes. Prostaglandins Other Lipid Mediat. 2002;68-69:3-58.
6. 2. Annu Rev Pharmacol Toxicol. 1999;39:175-189.
7. 2 enzymes: classification and characterization. Biochim Biophys Acta. 2000;1488(1-2):1-19.
8. 2 in human acute pancreatitis. Gastroenterol. 1989;97(6):1521-1526.
9. 2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion. 1992;52(3-4):232-236.
10. 2 levels in patients with acute pancreatitis. Res Commun Mol Pathol Pharmacol. 2001;109(3-4):159-164.
11. 2 activity in acute pancreatitis: a prognostic marker for early identification of patients at risk. Clin Chem Lab Med. 2002;40:293-297.
12. 2 in acute pancreatitis: an experimental study in rats. Gut. 1997;40(3):386-392.
13. 2 activity in body fluids and pancreatic tissue in patients with acute necrotising pancreatitis. Eur J Surg. 1999;165(1):35-42.
14. 2 in rats. Toxicon. 2005;46(8):921-926.
15. Emonds-Alt X, Doutremepuich JD, Heaulme M, et al. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol. 1993;250:403-413.
16. Costa SKP, Esquisatto LCM, Camargo E, et al. Comparative effect of Phoneutria nigriventer spider venom and capsaicin on the rat paw oedema. Life Sci. 2001;69:1573-1585.
17. Hirata M, Hayashi I, Yoshimura K, et al. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats. Br J Pharmacol. 2002;135:29-36.
18. Storck G. Fat necrosis in acute pancreatitis. Morphological and chemical study in the rat. Acta Chir Scand. 1971;47:1-36.
19. Brain SD, Williams TJ. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol. 1985;86:855-860.
20. Bradley PP, Priebat MD, Christensen MD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
21. 2 on mast-cell histamine release and paw oedema in the rat. Br J Pharmacol. 1977; 59(3):440P-441P.
22. Pennefather JN, Lecci A, Candenas ML, et al. Tachykinins and tachykinin receptors: a growing family. Life Sci. 2004;74(12):1445-1463.
23. Harrison S, Geppetti P. Substance P. Int J Biochem Cell Biol. 2001;33(6): 555-576.
24. Bhatia M, Saluja AK, Hofbauer B, et al. Role of substance P and the neurokinin-1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A. 1998;95:4760-4765.
25. Grady EF, Yoshimi SK, Maa J, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol. 2000;130(3):505-512.
26. Lau HY, Wong FL, Bhatia M. A key role of neurokinin 1 receptors in acute pancreatitis and associated lung injury. Biochem Biophys Res Commun. 2005;327:509-515.
27. Lau HY, Bhatia M. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis. J Pathol. 2006;208(3):364-371.
28. Maa J, Grady EF, Yoshimi SK, et al. Substance P is a determinant of lethality in diet-induced hemorrhagic pancreatitis in mice. Surgery. 2000;128:232-239.
29. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32:1-46.
30. Griesbacher T, Lembeck F. Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br J Pharmacol. 1992;107(2): 356-360.
31. Griesbacher T, Kolbitsch C, Tiran B, et al. Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caerulein-induced pancreatitis in rats. Naunyn Schmiedebergs Arch Pharmacol. 1995;352(5):557-564.
32. Griesbacher T, Rainer I, Tiran B, et al. Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats. Br J Pharmacol. 2002; 137(5):692-700.
33. Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest. 1997;100: 1853-1862.
34. Gomez-Cambronero LG, Sabater L, Pereda J, et al. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy. 2002;1(4):393-403.
35. Ramudo L, Manso MA, Sevillano S, et al. Kinetic study of TNF-alpha production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bile-pancreatic duct obstruction. J Pathol. 2005; 206(1):9-16.
36. Norman JG, Fink GW, Denham W, et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci. 1997;42:1783-1788.
37. Pereda J, Sabater L, Aparisi L, et al. Interaction between cytokines and oxidative stress in acute pancreatitis. Curr Med Chem. 2006;13(23): 2775-2787.
38. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988; 241(4870):1218-1221.
39. Tiffany CW, Burch RM. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 1989;247(2): 189-192.
40. Lee HR, Ho WZ, Douglas SD. Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. Clin Diagn Lab Immunol. 1994;1(4):419-423.
41. 2 homologues: dissociation between enzymatic and biological activities. Eur J Pharmacol. 1998;343:257-263.
42. Landucci EC, de Castro RC, Toyama M, et al. Inflammatory oedema induced by the lys-49 phospholipase A(2) homologue piratoxin-I in the rat and rabbit. Effect of polyanions and p-bromophenacyl bromide. Biochem Pharmacol. 2000;59(10):1289-1294.
43. 2 isolated from Crotalus durissus sp. in the rat dorsal skin: a role for mast cells and sensory C-fibers. Toxicon. 2003;41(7):823-829.
44. 2. Toxicon. 2003;42(8):947-962.
45. 2 into the rat pleural cavity. Toxicon. 2000;38:1773-1785.
46. 2: a role for cell surface glycosaminoglycans. Biochem Pharmacol. 2002;63(1): 65-72.
47. Geppetti P, Maggi CA, Perretti F, et al. Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart. Br J Pharmacol. 1988;94(2):288-290.
48. Saria A, Martling CR, Yan Z, et al. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis. 1988;137(6):1330-1335.
49. Perkins MN, Forster PL, Dray A. The involvement of afferent nerve terminals in the stimulation of ion transport by bradykinin in rat isolated colon. Br J Pharmacol. 1988;94(1):47-54.
50. Linardi A, Costa SK, da Silva GR, et al. Involvement of kinins, mast cells and sensory neurons in the plasma exudation and paw oedema induced by staphylococcal enterotoxin B in the mouse. Eur J Pharmacol. 2000;399(2-3):235-242.
51. Figini M, Emanueli C, Grady EF, et al. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol. 1997;272:G785-G793.